The targeted protein degradation enabling technologies market, featuring a healthy pipeline of novel therapeutics, is anticipated to be worth over USD 3.3 billion by 2030, predicts Roots Analysis | #biotech # Market research # market # pharma
The targeted protein degradation enabling technologies market, featuring a healthy pipeline of novel therapeutics, is anticipated to be worth over USD 3.3 billion by 2030, predicts Roots Analysis | #biotech # Market research # market # pharma
The soft tissue sarcoma market is projected to be worth over USD 420 million in 2030, growing at an annualized rate of 27.54% during the period 2021-2030, claims Roots Analysis | #biotech # Market research # market # pharma
The polycystic ovary syndrome market, is anticipated to be worth USD 5 billion by 2031, growing at an annualized rate of 4%, claims Roots Analysis | #biotech # Market research # market # pharma